S
GPCR icon

SignatureFD’s Structure Therapeutics GPCR Stock Holding History

SignatureFD’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.37K Hold
100
– – ﹤0.01% 2839
2026
Q1 		$4.82K Sell
100
-6,550
-98% -$448K ﹤0.01% 2790
2025
Q4 		$463K Hold
6,650
– – 0.01% 634
2025
Q3 		$186K Hold
6,650
– – ﹤0.01% 995
2025
Q2 		$138K Buy
6,650
+6,550
+6,550% +$144K ﹤0.01% 1081
2025
Q1 		$1.73K Hold
100
– – ﹤0.01% 2916
2024
Q4 		$2.71K Hold
100
– – ﹤0.01% 2777
2024
Q3 		$4.39K Hold
100
– – ﹤0.01% 2613
2024
Q2 		$3.93K Hold
100
– – ﹤0.01% 2591
2024
Q1 		$4.29K Hold
100
– – ﹤0.01% 2585
2023
Q4 		$4.08K Hold
100
– – ﹤0.01% 2565
2023
Q3 		$5.04K Hold
100
– – ﹤0.01% 2492
2023
Q2 		$4.16K Hold
100
– – ﹤0.01% 2577
2023
Q1 		$2.38K Buy
+100
New +$2.35K ﹤0.01% 2752

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

SignatureFD's GPCR Position: Q2 2026 in Review

SignatureFD held its Structure Therapeutics (GPCR) position steady in Q2 2026 at 100 shares worth $5.37K. The position accounts for ﹤0.01% of the portfolio, ranked #2839.

SignatureFD first reported a position in GPCR in Q1 2023 and has held it in 14 quarters since. The position peaked at $463K in Q4 2025. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • SignatureFD held 100 shares of Structure Therapeutics worth $5.37K as of Q2 2026.
  • SignatureFD left its Structure Therapeutics share count unchanged in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2839 holding.
  • SignatureFD first reported a position in Structure Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • SignatureFD's Structure Therapeutics position peaked at $463K in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.